Discovering cancer subtypes by tracking cancer progression with transcriptomic data through the multi-stage process of cancer development.

dc.contributor.advisorBendou, Hocine
dc.contributor.authorLivesey, Michelle Chantel
dc.date.accessioned2024-04-02T14:20:52Z
dc.date.accessioned2024-05-17T07:57:45Z
dc.date.available2024-04-02T14:20:52Z
dc.date.available2024-05-17T07:57:45Z
dc.date.issued2023
dc.descriptionPhilosophiae Doctor - PhDen_US
dc.description.abstractBackground: The development of cancer is driven by genomic alterations, which become more heterogeneous as the disease progresses throughout the stages. Consequently, cancer patients have differential levels of sensitivity to treatment. Tumor heterogeneity thus contributes to therapeutic failure, which ultimately leads to the generally poor prognosis and poor overall survival outcome associated with cancer. Introduction: Transcriptomic profiles can be used to track cancer progression based on gene expression changes that occur throughout the multi-stage process of cancer development. The accumulated genetic changes can be detected when gene expression levels in advanced-stage are less variable but show high variability in early-stage. Normalizing advanced-stage expression samples with early-stage and clustering of the normalized expression samples can reveal cancers with unique gene expression patterns based on cancer progression. Aims: A computational method was employed to investigate cancer progression through RNASeq expression profiles across the multi-stage process of cancer development. The method was assessed in a subtype of the heterogeneous kidney cancer and enabled the discovery of in-depth cancer subtypes based on the differences in gene expression profiles. Methods: A preliminary study was performed by downloading RNA-sequenced gene expression and associated phenotypic and survival profiles of Diffuse Large B-cell Lymphoma, Lung cancer, Liver cancer, Cervical cancer, and Testicular cancer from the UCSC Xena database. Similarly, Kidney renal clear cell carcinoma (KIRC) was downloaded as a validation dataset. Advanced-stage samples were normalized with early-stage to consider heterogeneity differences in the multi-stage cancer progression. The normalized gene expression of the preliminary cancer datasets was subjected to weighted gene co-expression network analysis. Gene modules were linked to cancer-related proteins and pathways using enrichment analyses.en_US
dc.identifier.urihttps://hdl.handle.net/10566/15267
dc.language.isoenen_US
dc.publisherUniversity of the Western Capeen_US
dc.rights.holderUniversity of the Western Capeen_US
dc.subjectCancer progressionen_US
dc.subjectTranscriptomic profilesen_US
dc.subjectNormalizationen_US
dc.subjectCancer heterogeneityen_US
dc.subjectSubtypingen_US
dc.titleDiscovering cancer subtypes by tracking cancer progression with transcriptomic data through the multi-stage process of cancer development.en_US
dc.typeThesisen_US

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
livesey_msc_phd_2023.pdf.pdf
Size:
2.56 MB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Plain Text
Description: